0001214659-17-004735.txt : 20170802 0001214659-17-004735.hdr.sgml : 20170802 20170802171912 ACCESSION NUMBER: 0001214659-17-004735 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170630 FILED AS OF DATE: 20170802 DATE AS OF CHANGE: 20170802 EFFECTIVENESS DATE: 20170802 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vivo Capital, LLC CENTRAL INDEX KEY: 0001674712 IRS NUMBER: 203075737 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-17467 FILM NUMBER: 171001251 BUSINESS ADDRESS: STREET 1: 505 HAMILTON AVENUE, SUITE 207 CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 650-688-0818 MAIL ADDRESS: STREET 1: 505 HAMILTON AVENUE, SUITE 207 CITY: PALO ALTO STATE: CA ZIP: 94301 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001674712 XXXXXXXX 06-30-2017 06-30-2017 false Vivo Capital, LLC
505 Hamilton Avenue, Suite 207 Palo Alto CA 94301
13F HOLDINGS REPORT 028-17467 N
Cinthia Sheu Chief Compliance Officer 650-688-0818 /s / Cinthia Sheu Palo Alto CA 08-02-2017 0 26 397070
INFORMATION TABLE 2 infotable.xml Aclaris therapeutics Common 00461U105 77524 2858569 SH SOLE 0 0 2858569 Advanced Accelerator Applications S.A. Common 00790T100 14007 358786 SH SOLE 0 0 358786 Agile Therapeutics, Inc. Common 00847L100 5677 1513975 SH SOLE 0 0 1513975 Aimmune Therapeutics, Inc. Common 00900T107 15971 776813 SH SOLE 0 0 776813 Akari Therapeutics Plc ADR 00972G108 2433 527842 SH SOLE 0 0 527842 Ascendis Pharma ADR 04351P101 49047 1766832 SH SOLE 0 0 1766832 Aurinia Pharmaceuticals Inc. Common 05156V102 6211 1013149 SH SOLE 0 0 1013149 Biohaven Pharmaceutical Holding Company Ltd Common 0G1196105 49420 1976818 SH SOLE 0 0 1976818 BioPharmX Corporation Common 09072X101 6752 14096338 SH SOLE 0 0 14096338 Capnia, Inc. Common 14066L105 7362 14695264 SH SOLE 14695264 0 0 Capnia, Inc. Warrant 14066L113 159 943858 SH SOLE 943858 0 0 KalVista Pharmaceuticals, Inc. Common 048349710 2210 300325 SH SOLE 0 0 300325 Codexis, Inc. Common 192005106 28857 5294825 SH SOLE 0 0 5294825 CRISPR Therapeutics AG Common H17182108 2385 148878 SH SOLE 0 0 148878 Dynavax Technologies Corporation Common 268158201 3472 359827 SH SOLE 0 0 359827 Eiger BioPharmaceuticals Common 28249U105 14118 1787091 SH SOLE 1787091 0 0 Foamix Pharmaceuticals Ltd. Common M46135105 3967 855000 SH SOLE 0 0 855000 Nabriva Therapeutics AG ADR 62957M104 42146 4021559 SH SOLE 0 0 4021559 Sierra Oncology, Inc. Common 74346L101 2853 2438270 SH SOLE 0 0 2438270 Regenxbio Inc. Common 75901B107 3247 164403 SH SOLE 0 0 164403 ReVance Therapeutics, Inc. Common 761330109 2043 77373 SH SOLE 0 0 77373 Selecta Biosciences, Inc. Common 816212104 22227 1119189 SH SOLE 0 0 1119189 Strongbridge Biopharma plc Ordinary Shares G85347105 21450 3000000 SH SOLE 0 0 3000000 Sunesis Pharmaceuticals, Inc. Common 867328700 1350 500000 SH SOLE 0 0 500000 Trevena, Inc. Common 89532E109 3974 1728000 SH SOLE 0 0 1728000 Verona Pharma Plc ADS 925050106 8208 704225 SH SOLE 704225 0 0